Spravato for PTSD: What We Know
While Spravato is FDA-approved for depression, many wonder about its potential for PTSD. At Next Step Psychiatry, we stay current on emerging research.
Current FDA Approval Status
Approved For:
- Treatment-resistant depression
- Major depressive disorder with suicidal ideation
NOT Currently Approved For:
- PTSD as a standalone diagnosis
The Research on Ketamine/Esketamine and PTSD
Emerging studies show promise:
- Reduced PTSD symptoms in some trials
- Particularly helpful for PTSD with co-occurring depression
- More research is ongoing
Treatment Options at Next Step Psychiatry
At Next Step Psychiatry, we can help if you have:
- PTSD with treatment-resistant depression
- PTSD with suicidal ideation
- Co-occurring PTSD and depression
Our experienced providers will evaluate your specific situation.
Comprehensive PTSD Care
We offer multiple treatment approaches for PTSD:
- Medication management
- Therapy coordination
- Spravato for qualifying patients
Learn More
Contact us at (678) 437-1659 to discuss your options. Check your insurance coverage at Next Step Psychiatry.
Related Topics
spravato for ptsdesketamine ptsdketamine ptsd treatmentptsd depression treatment
Ready to Explore Spravato Treatment?
If you're struggling with treatment-resistant depression, Spravato could be the breakthrough you've been waiting for. Contact Next Step Psychiatry in Atlanta for a consultation.